![]() |
|||||
![]() |
|
||
| Contact Us | Free E-Mail Updates | Journals | Register a colleague | |||
|
| ![]() my personal edition > hypertension > news
E-Mail this DGNews to a colleague
DGNews Fixed-Dose Combination 80 mg Telmisartan/25 mg Hydrochlorothiazide Approved in Europe for the Treatment of Essential HypertensionINGELHEIM, Germany -- April 14, 2008 -- The European Commission has granted marketing authorisation for fixed-dose combination 80 mg telmisartan/25 mg hydrochlorothiazide (MicardisPlus 80/25) in all 27 member states of the European Union. The combination drug was approved for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled by a lower-dose combination of 80 mg telmisartan/12.5 mg hydrochlorothiazide.
All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||